When it comes to dividends, healthcare usually goes into the back seat, such as Reit and energy reserves. Nevertheless, the stability of the sector, due to the aging population and consistent demand for medical services, makes it an underestimated source of sustainable income. Some medical companies not only offer impressive profitability, but also boast of strong financial indicators and long -term growth potential.
Do you want to add healthcare in your portfolio with a bonus? These three healthcare shares have a dividend yield of at least 6% – significant growth from the average dividend yield of the industry of 1.55%. Of course, it is very important to look at something more than just dividends when deciding which companies have a long -term place in your portfolio. Let’s look at each of these main dividend players and decide whether they are underestimated … or simply overpay.
Organon & Co. retains the target price, dividends, despite the indecision of analysts
Organization and Co. Dividends payments
- Dividend yield
- 7.32%
- Annual dividend
- $ 1.12
- Annual growth of dividends 3-year
- 25.99%
- Dividend payment coefficient
- 22.22%
- The next payment of dividends
- March 13
The history of the dividends of fire
Innovative studies in the field of health care rarely offer dividends; Instead, they decided to reinvest profit in research and development. Organon & Co. NYSE: OGN Backs of this trend, offering 6.84% dividend yield supported by a three -year -old growth rate of 25.99%. He pays competitive 22.63% of his cash flow as dividends and has a target price of $ 21.33 – a potential growth of 45.12% in combination with a consistent cash flow.
Before being lured by this huge dividend yield, it is important to consider reserves indicators that may signal that these payments will not last here. While short interest for Oranon & Co. They fell a little more than 9% last month, it still retains the total percentage of 16.58 million shares, which is 6.46% of the float. Analysts support the retention rating for OGN, which is produced in the light of a stable trend in price forecasting, which began in 2021.
The fall of short interest (and dividends) can make Walgreens winner
Walgreens Boots Alliance Payments Dividend
- Dividend yield
- 10.31%
- Annual dividend
- $ 1.00
- Annual growth of dividends 3-year
- -19,12%
- Dividend payment coefficient
- -9.77%
- Recent dividend payment
- December 12th
WBA dividends history
Alliance Walgreens Boots Alliance NASDAQ: WBA There were several difficult years. The decrease in pedestrian traffic in his physical retail stores remains a problem that has never restored the post-pandemia. In 2024, Walgreens announced that he would disable 1,200 additional places, extending the tendency to close his store. Despite the current dividend yield by 10.23%, over the past three years, shares have shown a decrease in the annual dividend growth by 19.12%.
Regardless of these stability reductions, the annual dividends of Walgreens by $ 1.00 can be a reliable cost in the light of a recent fall in short interest and low price. A short percentage has recently fallen by 13.58%, which indicates a sharp increase in investors’ confidence. He also surpassed his last consensus rating of EPS by more than 34%. This continues the tendency of growing income, which began in early 2024.
Since the shares are traded about a 52-week minimum, now there may be time to benefit from this retail seller of healthcare. Nevertheless, do not be surprised if there is another cut of dividends on the horizon.
Analysts are hidden on Spok Holdings
Spok Dividend Payments
- Dividend yield
- 7.39%
- Annual dividend
- $ 1.25
- Annual growth of dividends 3-year
- 35.72%
- Dividend payment coefficient
- 171.23%
- Recent dividend payment
- December 9th
Spok Dividend History
Spok Holdings, Inc. NASDAQ: Spok Offers an international exposition in the field of healthcare along with a dividend yield of 7.48%. This brings investors a constant three -year growth rate of dividends by 35.72%, which can be attractive in the inflationary environment.
In terms of stability, everything does not look great for Spok. It retains the unfortunate dividend payment coefficient of 171.23% – more than half the threshold of 75%, usually used to indicate a dividend trap. If you decide to invest in Spok Holdings, expect that in the near future a reduction in dividends.
The opinions of analysts about SPOK are divided. He supports one retention rating at the target price of consensus of $ 15. This is a potential drawback of 8.59%, but there are several positive indicators that you may want to consider. The short percentage of Spok Holdings fell by 6.56% last month, and only 1.59% of the shares decreased. Despite this, Spok supports a risky play, which should be approached with caution.
Before considering Spok, you will want to hear it.
Marketbeat monitors the highest and most effective analysts with the most effective Wall Street analysts and promotions that they recommend to their customers daily. Marketbeat has identified five shares that leading analysts quietly whisper to their clients to buy now before a wider market is won … and Spok was not on the list.
While Spok is currently a rating of “deductions” among analysts, analysts with the highest rating believe that these five promotions are better buying.
View five shares here
Marketbeat has just published its list of 10 cheap shares that have been missed by the market and can be seriously underestimated. Enter your email address and below to see which companies have compiled a list.
Get this free report